https://orcid.org/0000-0001-6037-6841
About the Authors
- Alexandra C. Willcox
-
Roles Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft
Affiliations Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America, Medical Scientist Training Program, University of Washington, Seattle, Washington, United States of America, Molecular and Cellular Biology Program, University of Washington, Seattle, Washington, United States of America
- Kevin Sung
-
Roles Data curation, Formal analysis, Methodology, Software, Validation, Visualization, Writing – review & editing
Affiliation Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
- Meghan E. Garrett
-
Roles Investigation, Methodology, Writing – review & editing
Affiliations Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America, Molecular and Cellular Biology Program, University of Washington, Seattle, Washington, United States of America
- Jared G. Galloway
-
Roles Data curation, Software, Writing – review & editing
Affiliation Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
- Jesse H. Erasmus
-
Roles Funding acquisition, Resources, Writing – review & editing
Affiliations Department of Microbiology, University of Washington, Seattle, Washington, United States of America, HDT Bio, Seattle, Washington, United States of America
- Jennifer K. Logue
-
Roles Resources, Writing – review & editing
Affiliation Department of Medicine, University of Washington, Seattle, Washington, United States of America
- David W. Hawman
-
Roles Funding acquisition, Resources, Writing – review & editing
Affiliation Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America
- Helen Y. Chu
-
Roles Funding acquisition, Resources, Writing – review & editing
Affiliation Department of Medicine, University of Washington, Seattle, Washington, United States of America
- Kim J. Hasenkrug
-
Roles Funding acquisition, Resources, Writing – review & editing
Affiliation Laboratory of Persistent Viral Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America
- Deborah H. Fuller
-
Roles Funding acquisition, Resources, Writing – review & editing
Affiliations Department of Microbiology, University of Washington, Seattle, Washington, United States of America, Infectious Diseases and Translational Medicine, Washington National Primate Research Center, Seattle, Washington, United States of America, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, Washington, United States of America
- Frederick A. Matsen IV
-
Roles Funding acquisition, Methodology, Supervision, Writing – review & editing
Affiliation Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
- Julie Overbaugh
-
Roles Conceptualization, Funding acquisition, Resources, Supervision, Writing – original draft, Writing – review & editing
* E-mail: joverbau@fredhutch.org
Affiliation Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
Competing Interests
I have read the journal’s policy and the authors of this manuscript have the following competing interests: J.H.E. has equity interest in HDT Bio. J.H.E. is a consultant for InBios. D.H.F. is a consultant for Gerson Lehrman Group, Orlance, Abacus Bioscience, HDT Bio, Immusoft, and GE Global Health. J.H.E. is a co-inventor on U.S. patent application no. 62/993,307 “Compositions and methods for delivery of RNA” pertaining to the LION formulation. H.Y.C. reported consulting with Ellume, Pfizer, The Bill and Melinda Gates Foundation, Glaxo Smith Kline, and Merck. She has received research funding from Gates Ventures, Sanofi Pasteur, and support and reagents from Ellume and Cepheid outside of the submitted work.